Literature DB >> 29396640

[Neurophysiology of atopic pruritus].

N H Meyer1, B Gibbs1, M Schmelz2, B Homey3, U Raap4.   

Abstract

Pruritus is one of the major symptoms of inflammatory skin diseases and strongly affects the quality of life in patients. Although the perception of pruritus and pain are closely intertwined, pruritus represents a distinct sensation, which is also significantly different to pain at a neurophysiological level. The pathophysiological basis of chronic and acute pruritus is not fully understood. Besides histamine, a plethora of different neuromediators of itch, including neurotrophins, neuropeptides and their corresponding receptors, have been identified. In atopic dermatitis the release of these mediators leads to an activation of immune cells, such as mast cells and eosinophilic granulocytes, which in turn release neuromediators and cytokines that activate peripheral neurons. This review focuses on the neurophysiological interactions which regulate pruritus and summarizes the function of neurological and inflammatory mediators in atopic pruritus.

Entities:  

Keywords:  Atopic dermatitis; Cytokines; Eosinophilic granulocytes; Neuropeptides; Neurotrophins

Mesh:

Substances:

Year:  2018        PMID: 29396640     DOI: 10.1007/s00105-018-4128-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  47 in total

1.  Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism.

Authors:  M Steinhoff; N Vergnolle; S H Young; M Tognetto; S Amadesi; H S Ennes; M Trevisani; M D Hollenberg; J L Wallace; G H Caughey; S E Mitchell; L M Williams; P Geppetti; E A Mayer; N W Bunnett
Journal:  Nat Med       Date:  2000-02       Impact factor: 53.440

2.  Correlation of IL-31 serum levels with severity of atopic dermatitis.

Authors:  Ulrike Raap; Katja Wichmann; Manuela Bruder; Sonja Ständer; Bettina Wedi; Alexander Kapp; Thomas Werfel
Journal:  J Allergy Clin Immunol       Date:  2008-08       Impact factor: 10.793

3.  Cowhage-evoked itch is mediated by a novel cysteine protease: a ligand of protease-activated receptors.

Authors:  Vemuri B Reddy; Aurel O Iuga; Steve G Shimada; Robert H LaMotte; Ethan A Lerner
Journal:  J Neurosci       Date:  2008-04-23       Impact factor: 6.167

Review 4.  Itch and pain differences and commonalities.

Authors:  Martin Schmelz
Journal:  Handb Exp Pharmacol       Date:  2015

5.  Scratching an itch.

Authors:  Barbara Namer; Peter Reeh
Journal:  Nat Neurosci       Date:  2013-02       Impact factor: 24.884

6.  Human basophils are a source of - and are differentially activated by - IL-31.

Authors:  U Raap; M Gehring; S Kleiner; U Rüdrich; B Eiz-Vesper; H Haas; A Kapp; B F Gibbs
Journal:  Clin Exp Allergy       Date:  2017-02-01       Impact factor: 5.018

Review 7.  Itch.

Authors:  Gil Yosipovitch; Malcolm W Greaves; Martin Schmelz
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

8.  Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils.

Authors:  O Noga; C Englmann; G Hanf; A Grützkau; S Guhl; G Kunkel
Journal:  Clin Exp Allergy       Date:  2002-09       Impact factor: 5.018

9.  Human eosinophils produce biologically active IL-12: implications for control of T cell responses.

Authors:  M Grewe; W Czech; A Morita; T Werfel; M Klammer; A Kapp; T Ruzicka; E Schöpf; J Krutmann
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

10.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

View more
  1 in total

1.  [Atopic eczema].

Authors:  A Wollenberg; T Biedermann
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.